Archive:
In addition to the majority of patients with type 1 diabetes, patients with more complex type 2 diabetes, patients with diabetic foot syndrome and pregnant patients with pre-existing diabetes or gestational diabetes are now also treated and trained in diabetology-focused practices (DSPs). In order to gain knowledge about the processes and results, a scientific institute for diabetology in private practice called winDiab was founded by diabetologists themselves five years ago. Since then, a number of concrete and practice-relevant questions have been examined specifically for this level of care and these evaluations, spots, annual reports and registers have been carried out by more than 100 DSPs with almost 160 diabetologists and their teams in their everyday practice. The results have a direct impact on the practical work of DSPs because they are used in communication with payers and lead to changes in the positioning of DSPs in the diabetological scene. In the future, winDiab's work will continue to contribute to ensuring that the necessary range of diagnostic and therapeutic options remains available for the treatment of patients. This article summarizes the work of winDiab and the most important results of the studies carried out over the last five years. At the same time, it is a description of the position of the DSPs and shows how their contribution can be to the scientific development of diabetology.
28.05.2013
Dr. Nikolaus Scheper is a general practitioner, board member of the Federal Association of Resident Diabetologists in Germany (BVND) and founding partner of the non-profit Scientific Institute of Resident Diabetologists (windiab). He is co-owner of the practice Drs. Scheper & Schneider in Marl and is a member of the “Marler Ärztenetz” (MAN) as well as a member of the “Pro-Gesund” network of the Federal Miners’ Association. His practice is also an academic teaching practice at the Ruhr University Bochum.
28.05.2013
Prof. Dr. Bertram Häussler compiled and presented the "Drug Atlas" on behalf of the vfa (Association of German Pharmaceutical Manufacturers), which also addresses innovations. In 2002, Häussler was appointed honorary professor at the Technical University of Berlin, where he teaches "Economics of the Pharmaceutical Industry." He has been managing director of the IGES Institute, Berlin, since 1990 and chairman of the board since 2006.
28.05.2013
Prof. Dr. Gerd Glaeske recently published the TK Innovation Report, which takes a decisive stance on innovations. Glaeske has been a professor of drug application research at the Center for Social Policy at the University of Bremen since 1999, head of the Drug Advice and Drug Information research unit, and co-head of the Department of Health Economics, Health Policy, and Health Services Research at the Center for Social Policy (ZeS) at the University of Bremen since 2007. He is also a member of the MVF scientific advisory board.
28.05.2013
What does a mail-order pharmacy like DocMorris have to do with health services research? More than you might think, as Prof. Dr. rer.nat. Christian Franken, the chief pharmacist at DocMorris, explains in an interview with “Monitor Healthcare Research”. Because the mail order pharmacy, which operates from the Netherlands, has a big advantage: over 2 million patient histories!
28.05.2013
As a current analysis by the information service provider INSIGHT Health shows, there are regional differences in the medication provided to children and adolescents with attention deficit hyperactivity disorder, or ADHD for short. The ADHD stronghold in terms of daily therapy doses (DDD) per capita is Lower Franconia.
28.05.2013
Prof. Dr. Eberhard Wille, the deputy chairman of the Advisory Council for the Assessment of Developments in the Health Care System, prepared a report on behalf of the German Society for Integrated Care in the Health Care System (DGIV). His conclusion: There are definitely options, but also obstacles that stand in the way of a goal-oriented integration of DMP with integrated forms of care; although - status today - the latter seem to predominate.
28.05.2013
„"Now, for an initial five years, Knieps will help the company health insurance funds rebuild what he demolished as a top civil servant," wrote the Frankfurter Allgemeine Zeitung (FAZ) on its online portal. "Monitor Versorgungsforschung" spoke with the former managing director of policy at the AOK Federal Association, later head of the "Statutory Health Insurance, Long-Term Care Insurance" department at the Federal Ministry of Health and Social Security, and, after leaving the BMG, partner at the business and political consultancy Wiese Consult, about fundamental political, economic, and social issues he intends to advance in his new position as chairman of the newly founded BKK umbrella association.
28.05.2013
Sensor-assisted pump therapy (SuP) has existed since 2006 by combining insulin pumps and continuous glucose monitoring, or CGM for short. While this new form of therapy is being prescribed to a much greater extent, especially for type 1 diabetics in other European countries, there is already general reimbursement in the Netherlands, Switzerland, Israel, Slovenia, Sweden, Ireland, Slovakia, Estonia and Austria exists, penetration in Germany is rather low. Because CGM is currently not reimbursable in this country - so each health insurance company decides on a case-by-case basis. On November 23rd last year, the G-BA commissioned IQWiG, which published a preliminary report plan on “Continuous glucose measurement with real-time measuring devices” on April 18th this year, which was published on July 20th after a hearing on July 9th. was finalized in October. This is now the basis of a preliminary assessment that will be published in the first quarter of 2014, which will then be submitted for hearing again. Only then – in the third quarter of next year – will the G-BA decide on reimbursement eligibility.
28.05.2013
The effects of demographic change have prompted the DGbV to set up a working group called “65 Plus”. Last but not least, the DGbV calls for a stronger citizen-oriented approach to older, particularly mentally or physically impaired citizens in the German healthcare system. The newly formed group serves two purposes. On the one hand, people over 65 who are still fit should be encouraged to continue to do everything in their power to get many more fulfilling years out of their lives. On the other hand, older, multimorbid and polypharmaco-treated citizens should also be protected from damage caused by over-, under- or incorrect care. Three experts spoke about the second set of topics at a “65 Plus” kick-off event in Berlin.